Transcription of Reflection paper on the dissolution specification for ...
{{id}} {{{paragraph}}}
10 August 2017. EMA/CHMP/CVMP/QWP/336031/2017. Committee for Medicinal Products for Human use (CHMP). Committee for Medicinal Products for Veterinary use (CVMP). Quality Working Party (QWP). Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action Draft agreed by the QWP March 2016. Draft adopted by the CHMP for release for consultation March 2016. Draft adopted by the CVMP for release for consultation April 2016. Start of public consultation 13 May 2016. End of consultation (deadline for comments) 13 August 2016.
Reflection paper on the dissolution specification for generic solid oral immediate release products with systemic action EMA/CHMP/CVMP/QWP/336031/2017 Page 2/10
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Dissolution test for solid dosage, FDA Guidance for Industry Dissolution Testing, Dissolution, Solid, Dosage, Comparison of dissolution profile of extended, Test, Dissolution test, Dissolution Method Development for Immediate, Dissolution Method Development for Immediate Release Solid, Guideline for Bioequivalence Studies for, Solid dosage, COMPARISON OF DISSOLUTION PROFILES:, COMPARISON OF DISSOLUTION PROFILES: CURRENT GUIDELINES